Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter Study

Figure 2

Failure-free survival (FFS) of patients. The estimated FFS rate was 68.3%  ±  7.6 with mean FFS time of 53.3 months ±4.9.